• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

J B Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 303.0
  • ISIN : INE572A01036
1,623.20 8 (0.46%)
  • As on 28 Mar 2025 (EOD)

  • Today’s Low

    1,615.00

  • Today’s High

    1,668.95

  • Open

    1,625.00

  • Perv Close

    1,615.70

  • 52W Low

    1,433.60

  • 52W High

    2,030.00

Key Indicators

  • P/E(TTM)

    40.17

  • Mar.Cap (₹Cr.)

    25,269.52

  • Div & Yield %

    0.75

  • Book Value(₹)

    202.81

  • Debt-Equity Ratio

    0.46

  • AGM Date

    28-Mar-2025

  • EPS

    40.38

  • P/E Ratio

    40.17

Financials Ratios

  • Debt-Equity Ratio

    0.18

  • Mar.Cap (₹Cr.)

    25,269.52

  • RONW (%)

    20.45

  • ROCE (%)

    24.90

Score Board

  • Equity (₹ in Cr.)

    15.57

  • BV (₹)

    202.80

  • Sales( ₹ in Cr.)

    3,298.64

  • NP (in Cr.)

    531.66

  • NP Var(%)

    38.0

  • Div%

    1225.0

  • CPS (₹)

    42.80

  • EPS (₹)

    34.20

  • Traded Value (₹ in Lakhs)

    25,253.96

  • 52 Week High

    2,030.00

  • 52 Week Low

    1,433.60

  • Price BSE

    1622.0

  • Price NSE

    1,623.00

  • Market Capital( in Cr.)

    25,253.96

  • P/C Ratio

    37.90

  • P/E Ratio

    47.50

  • Price Vs.BV

    34.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74 1,501.19
Excise Duty 3,251.81 2,852.64 2,158.74 1,839.21 1,594.24 1,462.95
Net Sales 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74 1,501.19
Other Income 34.67 8.65 38.61 115.92 47.13 36.53
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 3,333.32 2,892.81 2,228.49 2,007.92 1,687.88 1,537.72
EXPENDITURE :
Raw Materials 3,251.81 2,852.64 2,158.74 1,839.21 1,594.24 1,462.95
Power & Fuel Cost 3,251.81 2,852.64 2,158.74 1,839.21 1,594.24 1,462.95
Employee Cost 565.38 499.95 399.06 305.98 293.78 257.98
Other Manufacturing Expenses 88.96 90.33 63.58 55.96 63.75 56.79
Selling & Administrative Expenses 446.93 394.90 305.91 204.68 205.02 212.12
Miscellaneous Expenses 88.96 90.33 63.58 55.96 63.75 56.79
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,594.98 2,365.77 1,757.20 1,414.21 1,338.32 1,268.44
Operating Profit 208.88 197.56 168.72 147.29 138.60 145.81
Interest 40.52 34.31 4.95 7.19 2.94 4.57
Gross Profit 738.34 527.04 471.29 593.71 339.56 269.28
Depreciation 135.24 111.99 71.28 67.36 65.09 54.82
Profit Before Tax 738.34 527.04 471.29 593.71 339.56 269.28
Tax 145.10 83.35 122.50 137.50 82.50 75.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 49.49 54.80 -12.21 9.12 -10.60 11.30
Reported Net Profit 543.36 388.89 361.00 447.08 268.14 182.06
Extraordinary Items 738.34 527.04 471.29 593.71 339.56 269.28
Adjusted Net Profit 543.36 388.89 361.00 447.08 268.14 182.06
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 190.17 137.35 127.52 127.52 85.01 40.12
P & L Balance carried down 543.36 388.89 361.00 447.08 268.14 182.06
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 1,225.00 887.50 825.00 825.00 550.00 250.00
Dividend Per Share(Rs) 12.25 17.75 16.50 16.50 11.00 5.00
Earnings Per Share-Unit Curr 35.07 25.15 46.71 57.85 33.70 22.15
Book Value 190.17 137.35 127.52 127.52 85.01 40.12
Book Value(Adj)-Unit Curr 190.17 137.35 127.52 127.52 85.01 40.12

Shareholding Pattern

  • Promoter Group

    53.66%

  • Public Share Holding

    46.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 83,464,664 53.66 83,464,664 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 83,464,664 53.66 83,464,664 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 3,060 0.00 3,060 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 7,000 0.00 4,000 4
Foreign Bank 1,000 0.00 1,000 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 22,768,880 14.64 22,768,880 237
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,943,745 1.25 1,940,745 12
Mutual Funds / UTI 22,669,464 14.57 22,667,464 29
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 905,641 0.58 905,641 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 48,298,790 31.05 48,290,790 294
2] Non Institution
Bodies Corporate 786,703 0.51 781,703 382
Clearing Members 303 0.00 303 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 997,557 0.64 997,557 1,668
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 525,392 0.34 525,392 973
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,686,716 1.08 1,686,716 3
Individuals holding nominal share capital up to Rs. 1 lakh 19,195,110 12.34 18,690,380 58,750
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,200 0.00 2,200 5
Others 591,293 0.38 591,293 2
Sub Total 23,785,274 15.29 23,275,544 61,786
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 155,548,728 100.00 155,030,998 62,081

Company Background

J B Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • J B Chemicals & Pharmaceuticals Ltd
  • BSE Code : 303.0
  • ISIN : INE572A01036

  • Incorporation Year

    1976

  • Registered Office

    Neelam Centre 4th Floor
    B-Wing Hind Cycle Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-2482 2222/2493 0918

  • FAX

    91-022-24930534

  • Chairman

    Arun Duggal

  • Managing Director

  • Company Secretary

    SANDEEP PHADNIS

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Datamatics Financial Services
    Plot No B-5 MIDC ,
    Part B Cross Lane ,Marol Andheri(E)
    Mumbai - Mumbai-400093

J B Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
J B Chemicals & 1,622.20 3,333.32 3,298.64 40.17 24.83
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92